BOSTON, Dec. 22, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering immuno-oncology and RNA for the treatment of high risk and advanced cancer, ...
The room we are in is locked. It is windowless and lit from above by a fluorescent bulb. In the hallway outside—two stories beneath the city of London—attendants in dark suits patrol silently, giving ...
WASHINGTON, Oct 24 (Reuters) - The U.S. will expand the use of facial recognition technology to track non-citizens entering and leaving the country in order to combat visa overstays and passport fraud ...
TransCode acquires 100% of the issued and outstanding interests of Polynoma from CK Life Sciences Concurrent equity investment of $25 Million from CK Life Sciences into TransCode TransCode expands its ...
(RTTNews) - TransCode Therapeutics (RNAZ) has entered into a definitive agreement to acquire Polynoma, a privately-held biotechnology immuno-oncology company. Polynoma is developing a late-stage ...
What happens when a trusted tech brand makes a decision that fundamentally alters how its products are used? For Synology, the answer is unfolding in real-time, as its recent move to eliminate ...
All the Latest Game Footage and Images from Non-Linear Text Quests: Return of Red Riding Hood Enhanced Edition This visual novel is a collection of alternative realities. Visit wolf’s den and solve ...
Linear, an enterprise software maker that competes with many of Atlassian’s products, on Tuesday announced that it raised $82 million in a Series C funding round led by Accel. The round, which also ...
SAN FRANCISCO, June 10 (Reuters) - Enterprise software maker Linear has raised an $82 million Series C funding round valuing the startup at $1.25 billion, the company said on Tuesday. Venture capital ...
EIM Technologies' Kickstarter campaign ended on April 16, 2025, reaching ~$108,000 in pledges. The book and associated kits can now be ordered from EIM directly, with details below. EIM used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results